Manufacturing Of Covishield
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
"Vaccine Hesitancy Greatest Threat" In Overcoming Covid: Adar Poonawalla
Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, today said vaccine hesitancy was the "greatest threat" in overcoming the pandemic.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
"Vaccine Hesitancy Greatest Threat" In Overcoming Covid: Adar Poonawalla
Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, today said vaccine hesitancy was the "greatest threat" in overcoming the pandemic.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
